DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 141 filers reported holding DIPLOMAT PHARMACY INC in Q4 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $300,000 | +971.4% | 75,000 | +1174.2% | 0.00% | – |
| Q3 2019 | $28,000 | -90.0% | 5,886 | -87.3% | 0.00% | -100.0% |
| Q2 2019 | $281,000 | +83.7% | 46,233 | +75.5% | 0.00% | – |
| Q1 2019 | $153,000 | -77.9% | 26,340 | -26.2% | 0.00% | -100.0% |
| Q3 2018 | $693,000 | +231.6% | 35,711 | +244.3% | 0.00% | -77.8% |
| Q1 2018 | $209,000 | -27.4% | 10,373 | -27.9% | 0.01% | -25.0% |
| Q4 2017 | $288,000 | +476.0% | 14,387 | +354.4% | 0.01% | +500.0% |
| Q1 2017 | $50,000 | +4900.0% | 3,166 | +2298.5% | 0.00% | – |
| Q4 2016 | $1,000 | -97.6% | 132 | -91.2% | 0.00% | -100.0% |
| Q3 2016 | $42,000 | -76.3% | 1,503 | -76.8% | 0.00% | -78.6% |
| Q1 2016 | $177,000 | -66.5% | 6,473 | -58.1% | 0.01% | -65.9% |
| Q4 2015 | $528,000 | +1408.6% | 15,443 | +1160.7% | 0.04% | +1266.7% |
| Q3 2015 | $35,000 | -52.1% | 1,225 | -25.4% | 0.00% | -50.0% |
| Q2 2015 | $73,000 | – | 1,642 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |